bioAffinity Technologies logo

bioAffinity Technologies

BIAF | NASDAQ
Chart Builder DCF Calculator
$2.00
-$0.20 (-9.09%)
At close: Nov 16, 2026, 4:00 PM ET
$2.10
+$0.10 (+5.00%)
After-hours: Nov 16, 2026, 7:34 PM ET
-9.09%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
39.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #548/1021 (Top 54%)

Key Statistics

Market Data

Market Cap $12.57M
1D Range
1.96 2.13
52W Range
1.96 71.10

Valuation (TTM)

PE -0.04
PB 3.21
EV/EBITDA -0.87

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Loading financial charts...

Profile

As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lun...

Sector Healthcare
Employees 57
IPO Date Sep 1, 2022
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 6, 2026
EPS
-$5.89
Beat +81.30%
REV
$1.07M
Miss -43.82%
Next Earnings
Apr 5, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.